Publications by authors named "A A P Baron"

Magnetic nanoparticles (NPs) are gaining significant interest in the field of biomedical functional nanomaterials because of their distinctive chemical and physical characteristics, particularly in drug delivery and magnetic hyperthermia applications. In this paper, we experimentally synthesized and characterized new FeO-based NPs, functionalizing its surface with a 5-TAMRA cadaverine modified copolymer consisting of PMAO and PEG. Despite these advancements, many combinations of NP cores and coatings remain unexplored.

View Article and Find Full Text PDF

Menopause affects over a million individuals annually and is characterized by variable and declining ovarian hormones. Decreasing estrogen levels impact energy homeostasis and increases the risk of metabolic disorders. Energy expenditure is largely directed towards thermoregulation, which is modulated in part by estrogen receptor (ER) α expressing neurons in the hypothalamus.

View Article and Find Full Text PDF

Patients receiving palliative care experience stigma associated with their illness, personal identity, and healthcare utilization. These stigmas can occur at any stage of the disease process. Varying stigmas combine to cause palliative care patients to feel misunderstood, contribute to treatment barriers, and further negative stereotypes held by clinicians.

View Article and Find Full Text PDF

Allergen-specific immunotherapy (AIT) induces immune tolerance, showing the highest success rate (>95%) for insect venom while a much lower chance for pollen allergy. However, the molecular switches leading to successful durable tolerance restoration remain elusive. The primary outcome of this observational study is the comprehensive immunological cellular characterization during the AIT initiation phase, whereas the secondary outcomes are the serological and Th2-cell-type-specific transcriptomic analyses.

View Article and Find Full Text PDF
Article Synopsis
  • The human MRGPRD protein is part of a family of receptors that play a key role in detecting pain and itch, but it's not well-researched and has few known activating compounds.
  • The study identifies two new potent agonists, EP-2825 and EP-3945, that are about 100 times more effective than the previously known agonist, β-alanine.
  • The researchers also explored the structures of MRGPRD bound to these agonists, revealing unique binding interactions and flexibility in the receptor, which could help in creating new drugs targeting MRGPRD.
View Article and Find Full Text PDF